India has rejected requests from pharmaceutical companies to delay a year-end deadline for upgrading their manufacturing facilities to international standards, following the deaths of at least 24 children linked to toxic cough syrup.
The World Health Organization (WHO) has expressed “deep concern” over gaps in India’s drug safety regulations following the deaths of at least 20 children from contaminated cough syrups. The agency warned that such medicines could reach other countries through unregulated distribution channels.
10 Oct 2025-16:39
10 Oct 2025-12:34
